In a previous report evaluating FAK levels in 629 breast tumor samples from patients with mostly Stage I or II breast cancer, 25% had high FAK expression, while approximately 75% were classified as having not high FAK levels (11). This evidence concerns the gene PTK2 and breast carcinoma.